| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institute for Cancer Genetics,*the Department of Pathology,the Department of Medicine,Division of Pulmonary Medicine, and the Comprehensive Cancer Center,Columbia University, New York, New York
Wilms’ tumor (WT) has been considered a prototype for arrested cellular differentiation in cancer, but previous studies have relied on selected markers. We have now performed an unbiased survey of gene expression in WTs using oligonucleotide microarrays. Statistical criteria identified 357 genes as differentially expressed between WTs and fetal kidneys. This set contained 124 matches to genes on a microarray used by Stuart and colleagues (Stuart RO, Bush KT, Nigam SK: Changes in global gene expression patterns during development and maturation of the rat kidney. Proc Natl Acad Sci USA 2001, 98:5649–5654) to establish genes with stage-specific expression in the developing rat kidney. Mapping between the two data sets showed that WTs systematically overexpressed genes corresponding to the earliest stage of metanephric development, and underexpressed genes corresponding to later stages. Automated clustering identified a smaller group of 27 genes that were highly expressed in WTs compared to fetal kidney and heterologous tumor and normal tissues. This signature set was enriched in genes encoding transcription factors. Four of these, PAX2, EYA1, HBF2, and HOXA11, are essential for cell survival and proliferation in early metanephric development, whereas others, including SIX1, MOX1, and SALL2, are predicted to act at this stage. SIX1 and SALL2 proteins were expressed in the condensing mesenchyme in normal human fetal kidneys, but were absent (SIX1) or reduced (SALL2) in cells at other developmental stages. These data imply that the blastema in WTs has progressed to the committed stage in the mesenchymal-epithelial transition, where it is partially arrested in differentiation. The WT-signature set also contained the Wnt receptor FZD7, the tumor antigen PRAME, the imprinted gene NNAT and the metastasis-associated transcription factor E1AF.
Related articles in Am J Pathol:
This article has been cited by other articles:
 |
|
 |
|
  S. Metsuyanim, N. Pode-Shakked, K. M. Schmidt-Ott, G. Keshet, G. Rechavi, D. Blumental, and B. Dekel Accumulation of Malignant Renal Stem Cells Is Associated with Epigenetic Changes in Normal Renal Progenitor Genes Stem Cells, July 1, 2008; 26(7): 1808 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Behbakht, L. Qamar, C. S. Aldridge, R. D. Coletta, S. A. Davidson, A. Thorburn, and H. L. Ford Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated with Poor Survival Cancer Res., April 1, 2007; 67(7): 3036 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. N. H. Masckauchan, D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C.-M. Li, A. Khoo, B. Tycko, A. M.C. Brown, and J. Kitajewski Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2 Mol. Biol. Cell, December 1, 2006; 17(12): 5163 - 5172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Epping and R. Bernards A Causal Role for the Human Tumor Antigen Preferentially Expressed Antigen of Melanoma in Cancer. Cancer Res., November 15, 2006; 66(22): 10639 - 10642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gupta, B. R.G. Williams, S. M. Hanash, and J. Rawwas Cellular Retinoic Acid-Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma Cancer Res., August 15, 2006; 66(16): 8100 - 8108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dekel, S. Metsuyanim, K. M. Schmidt-Ott, E. Fridman, J. Jacob-Hirsch, A. Simon, J. Pinthus, Y. Mor, J. Barasch, N. Amariglio, et al. Multiple Imprinted and Stemness Genes Provide a Link between Normal and Tumor Progenitor Cells of the Developing Human Kidney. Cancer Res., June 15, 2006; 66(12): 6040 - 6049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yu, E. Davicioni, T. J. Triche, and G. Merlino The Homeoprotein Six1 Transcriptionally Activates Multiple Protumorigenic Genes but Requires Ezrin to Promote Metastasis Cancer Res., February 15, 2006; 66(4): 1982 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Li, A. A. Margolin, M. Salas, L. Memeo, M. Mansukhani, H. Hibshoosh, M. Szabolcs, A. Klinakis, and B. Tycko PEG10 Is a c-MYC Target Gene in Cancer Cells Cancer Res., January 15, 2006; 66(2): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Borczuk, H. K. Kim, H. A. Yegen, R. A. Friedman, and C. A. Powell Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-{beta} Receptor as a Repressor of Invasiveness Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 729 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Reichenberger, R. D. Coletta, A. P. Schulte, M. Varella-Garcia, and H. L. Ford Gene Amplification Is a Mechanism of Six1 Overexpression in Breast Cancer Cancer Res., April 1, 2005; 65(7): 2668 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Hofmann, L. Braydich-Stolle, L. Dettin, E. Johnson, and M. Dym Immortalization of Mouse Germ Line Stem Cells Stem Cells, February 1, 2005; 23(2): 200 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Li, C. E. Kim, A. A. Margolin, M. Guo, J. Zhu, J. M. Mason, T. W. Hensle, V. V.V.S. Murty, P. E. Grundy, E. R. Fearon, et al. CTNNB1 Mutations and Overexpression of Wnt/{beta}-Catenin Target Genes in WT1-Mutant Wilms' Tumors Am. J. Pathol., December 1, 2004; 165(6): 1943 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Tan, C. G. Rogers, J. T. Cooper, J. A. Ditlev, T. J. Maatman, X. Yang, K. A. Furge, and B. T. Teh Gene Expression Profiling of Renal Cell Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6315S - 6321S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Coletta, K. Christensen, K. J. Reichenberger, J. Lamb, D. Micomonaco, L. Huang, D. M. Wolf, C. Muller-Tidow, T. R. Golub, K. Kawakami, et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1 PNAS, April 27, 2004; 101(17): 6478 - 6483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Prindull and D. Zipori Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm Blood, April 15, 2004; 103(8): 2892 - 2899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Davies, M. Ladomery, P. Hohenstein, L. Michael, A. Shafe, L. Spraggon, and N. Hastie Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation Hum. Mol. Genet., January 15, 2004; 13(2): 235 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. O. Nielsen, F. D. Hsu, J. X. O'Connell, C. B. Gilks, P. H.B. Sorensen, S. Linn, R. B. West, C. L. Liu, D. Botstein, P. O. Brown, et al. Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology Am. J. Pathol., October 1, 2003; 163(4): 1449 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. TYCKO Genetic and Epigenetic Mosaicism in Cancer Precursor Tissues Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 43 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, X. J. Yang, T. T. Lavery, K. A. Furge, B. O. Williams, M. Tretiakova, A. Montag, N. J. Vogelzang, G. G. Re, A. J. Garvin, et al. Gene Expression Profiling of Favorable Histology Wilms Tumors and Its Correlation with Clinical Features Cancer Res., November 15, 2002; 62(22): 6598 - 6605. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
